Health
“Individuals suffering from mental illnesses have long faced disparity in the coverage they receive from their insurers, and the time is now to end this practice,” Commissioner Jones said. “The Mental Health Parity Act was created to ensure that people affected by mental illnesses receive the coverage they need, and insurers have an obligation to abide by this critical law.”
A panel of the U.S. Court of Appeals for the Ninth Circuit held several months ago that the California Mental Health Parity Act required Blue Shield of California to provide residential care treatment for a woman suffering from anorexia nervosa.
Blue Shield denied coverage on the ground its health plans exclude coverage for residential care treatment.
The panel held that denying coverage on that ground deprived a patient of critical services needed to treat a mental illness.
The panel found that the Mental Health Parity Act creates both a mandate (all insurers must cover listed mental illnesses) and a requirement of parity (an insurer must provide that coverage on terms no more restrictive than for physical illnesses).
Commissioner Jones strongly supports the panel’s analysis.
The panel’s decision is important not just for people suffering from anorexia nervosa. It applies to many other serious mental illnesses, including bipolar disorder, major depressive disorders, and pervasive developmental disorder or autism.
The commissioner has been particularly concerned about insurers’ denial of coverage to children in need of autism treatment. The panel decision upholds their rights.
The Commissioner’s brief comes in the context of Blue Shield’s request to the full Ninth Circuit Court that it set aside the panel’s decision. The commissioner urges the court to keep the panel decision on the books. See the brief below.
111011 Insurance Commissioner Mental Health Brief
- Details
- Written by: Editor
Consumers in possession of the candy should discard it immediately, Chapman reported.
Recent analysis of this candy by CDPH determined that Roopal Swad candy contained as much as 0.18 parts per million (ppm) of lead.
California considers candies with lead levels in excess of 0.10 ppm to be contaminated.
Roopal Swad candy is imported and distributed by India Imports & Exports Inc. in Los Angeles, which initiated the voluntary recall.
CDPH is currently working with the distributor to ensure that the contaminated candies are removed from the market place.
Sold in a 7-ounce (200 gram) clear plastic package, the candy is visible through the package and wrapped in silver foil with a dark brown design. The package label is yellow with the brand name “Roopal” at the top in a red oval. The words “Swad Candy” appear in the middle of the package.
Pregnant women and parents of children who may have eaten this candy should consult their physician or health care provider to determine if medical testing is needed. Information, including photos, is available on the CDPH Web site at the Roopal Swad Candy Imported From India Due to High Levels of Lead page.
Consumers who find this candy for sale should call the CDPH Complaint Hotline at 1-800-495-3232.
For more information about lead poisoning, contact your county childhood lead poisoning prevention program or public health department. Additional information is available on the CDPH Childhood Lead Poisoning Prevention page.
- Details
- Written by: Editor
How to resolve AdBlock issue?